ETF Evaluator:
GMO Beyond China ETF (BCHI)
Follow This ETF
(as of Aug 14)
Best Performing in Diversified Emerging Mkts Over the Last Year
| 114.0% | Nomura Focused Emerging Mrkts Eq ETF (EMEQ) |
| 81.0% | FT EM Human Flourishing ETF (FTHF) |
| 68.7% | First Trust Bloomberg Emr Mkt Dem ETF (EMDM) |
| 67.8% | Freedom 100 Emerging Markets ETF (FRDM) |
| 59.4% | Pacific NoS Global EM Equity Active ETF (GEME) |
Risk
Index
Risk
Index
ETF Details
GMO Beyond China ETF Overview
GMO Beyond China ETF (BCHI) is an actively managed International Equity Diversified Emerging Mkts exchange-traded fund (ETF). GMO launched the ETF in 2025.
The investment seeks total return.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing in equities of companies tied economically to markets (excluding China) that are not treated as developed markets in the MSCI World Index (“emerging markets”). It invests in companies that GMO believes are likely to benefit from growth in emerging markets and from the widespread trend of transitioning supply chains out of China to other emerging markets.
About GMO Beyond China ETF (BCHI)
There are 2 members of the management team with an average tenure of 1.46 years: George Sakoulis (2025) and Warren Chiang (2025). Management tenure is more important for actively managed ETFs than passive index ETFs.
GMO Beyond China ETF has 104 securities in its portfolio. The top 10 holdings constitute 49.5% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a diversified fund. The ETF is considered to have an ESG focus with its investment selection and management.
GMO Beyond China ETF is part of the Equity global asset class and is within the International Equity ETF group. GMO Beyond China ETF has 97.0% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 2.5% There is 97.0% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). GMO Beyond China ETF has 0.6% of the portfolio in cash.
Assets Under Management
The fund has $14 million in total assets, which is below the $3 billion average for the Diversified Emerging Mkts category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
BCHI Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The GMO Beyond China ETF expense ratio is above average compared to funds in the Diversified Emerging Mkts category. GMO Beyond China ETF has an expense ratio of 0.65%, which is 26% higher than its category average, making the fund expense ratio grade a D. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. GMO Beyond China ETF has a portfolio turnover rate of 30%, which indicates that it holds its assets around / 0.0 years. By way of comparison, the average portfolio turnover is 44% for the Diversified Emerging Mkts category.
Recently, in the month of June 2026, GMO Beyond China ETF returned -2.0%, which earned it a grade of B, as the Diversified Emerging Mkts category had an average return of -3.0%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.
GMO Beyond China ETF has a trailing yield of 1.92%, which is below the 2.41% category average.
The fund normally distributes its income annually and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
GMO Beyond China ETF Grades
Year to date, the ETF has returned 30.1%, 13.0 percentage points better than the category, which translates into a grade of A. The fund has returned 51.4% over the past year (grade of A).
For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about GMO Beyond China ETF, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
BCHI Trailing NAV Total Returns Data as of 6/30/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| BCHI Return (NAV) | -2.0% | 28.3% | 51.4% | na | na | na |
| BCHI Return (Price) | na | na | na | na | na | na |
| NAV +/- Price Return | na | na | na | na | na | na |
| Diversified Emerging Mkts Avg | -3.0% | 3.0% | 31.9% | 16.6% | 7.1% | 7.8% |
| BCHI Grade (NAV) | B | A | A | na | na | na |
| +/- Category (NAV) | 1.1% | 25.3% | 19.4% | na | na | na |
| BCHI Tax-Cost Ratio | na | na | 2.2% | na | na | na |
BCHI Annual NAV Total ReturnsData as of 6/30/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| BCHI Return (NAV) | 30.1% | na | na | na | na | na | na | na | na | na | na |
| BCHI Return (Price) | na | na | na | na | na | na | na | na | na | na | na |
| NAV +/- Price Ret | na | na | na | na | na | na | na | na | na | na | na |
| Diversified Emerging Mkts Avg | 17.1% | 29.2% | 6.7% | 12.8% | -18.8% | 2.3% | 12.7% | 18.2% | -14.6% | 33.7% | 10.9% |
| BCHI Grade (NAV) | A | na | na | na | na | na | na | na | na | na | na |
| +/- Category | 13.0% | na | na | na | na | na | na | na | na | na | na |
| Risk Measures | |
| Beta: | na |
| R-Squared: | na |
| Standard Deviation: | na |
| Category Risk Index: | na |
| Category Risk Rating: | |
| Total Risk Index: | na |
| Total Risk Rating: | |
| Portfolio Characteristics | |
| Yield: | 1.9% |
| Total Assets: | $ 15 Mil |
| Share Class Assets: | $ 15 Mil |
| Turnover: | 30.0% |
| Expense Ratio: | 0.65% |
| Index Fund: | No |
| Index Tracked: | N/A |
| Index Weighting: | 100% |
| Leveraged: | No |
| Socially Responsible Fund: | Yes |
| Capital Gains Distribution Frequency: | Annually |
| Income Distribution Frequency: | Annually |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 1.5 years | |||
| Average Tenure: 1.5 years | |||
| Managers (Year): Sakoulis George (2025), Chiang Warren (2025) | |||
Portfolio Composition (as of 6/30/26)
| # of Holdings: | 104 |
| % in Top 10 Holdings: | 49.5% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 97.0% |
Portfolio Allocation |
|
| Domestic Stock: | 2.5% |
| Foreign Stock: | 97.0% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.6% |
Purchase Information
| Legal Structure: | Open Ended Investment Company |
| Fund Family: | GMO |
| Phone Number: | 844-761-1102 |
| Website: | |
| Inception Date: | February 12, 2025 |
Expenses and Fees
| Expense Ratio (%): | 0.65% (Rating: Above Avg) |
| Category Average Expense Ratio (%): | 0.52% |
